Clinical trial

Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR…

NCT00339014 · Orexigen Therapeutics, Inc, Industry · Completed

Key facts

NCT number NCT00339014
Title Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity
Official title A Dose Parallel, Randomized, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Multiple Regimens of the Combination of Zonisamide CR Plus Bupropion SR in the Treatment of Subjects With Uncomplicated Obesity
Lead sponsor Orexigen Therapeutics, Inc, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Obesity
Intervention type Drug, Other
Interventions Zonisamide CR and Bupropion SR, Placebo
Enrollment 611
Start date May 1, 2006
Primary completion Aug 1, 2007
Completion Aug 1, 2007
First posted Jun 20, 2006
Last update posted Apr 22, 2008
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies